{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:44Z","timestamp":1790996744200,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T00:00:00Z","timestamp":1603324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11011-020-00636-w","type":"journal-article","created":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T02:02:37Z","timestamp":1603332157000},"page":"13-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Current and emerging therapeutic targets for Parkinson\u2019s disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Tanvi","family":"Pingale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girdhari Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,22]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/ene.13395","volume":"24","author":"CH Adler","year":"2017","unstructured":"Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG (2017) GBA mutations in Parkinson disease: earlier death but similar neuropathological features. Eur J Neurol 24:1363\u20131368. https:\/\/doi.org\/10.1111\/ene.13395","journal-title":"Eur J Neurol"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2217\/pgs.15.183","volume":"17","author":"V Altmann","year":"2016","unstructured":"Altmann V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, Rieder CR, Hutz MH (2016) Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson\u2019s disease. Pharmacogenomics 17:481\u2013488. https:\/\/doi.org\/10.2217\/pgs.15.183","journal-title":"Pharmacogenomics"},{"issue":"Suppl. 3","key":"636_CR3","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1016\/S1353-8020(09)70802-8","volume":"15","author":"E Angot","year":"2009","unstructured":"Angot E, Brundin P (2009) Dissecting the potential molecular mechanisms underlying alpha-synuclein cell-to-cell transfer in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(Suppl. 3):S143\u2013S147. https:\/\/doi.org\/10.1016\/S1353-8020(09)70802-8","journal-title":"Parkinsonism Relat Disord"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Chan HYE, Trojanowski JQ, Lee VM, Bonini NM (2002) Chaperone suppression of \u03b1-synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science 295:865\u2013868. https:\/\/doi.org\/10.1126\/science.1067389","journal-title":"Science"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/a:1020592719405","volume":"30","author":"G Barja","year":"1998","unstructured":"Barja G, Herrero A (1998) Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr 30:235\u2013243. https:\/\/doi.org\/10.1023\/a:1020592719405","journal-title":"J Bioenerg Biomembr"},{"key":"636_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"JM Beaulieu","year":"2011","unstructured":"Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182\u2013217. https:\/\/doi.org\/10.1124\/pr.110.002642","journal-title":"Pharmacol Rev"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mds.25844","volume":"29","author":"D Berg","year":"2014","unstructured":"Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson\u2019s disease. Mov Disord 29:454\u2013462. https:\/\/doi.org\/10.1002\/mds.25844","journal-title":"Mov Disord"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.08.040","volume":"658","author":"V Berge-Seidl","year":"2017","unstructured":"Berge-Seidl V, Pihlstrom L, Maple-Grodem J, Forsgren L, Linder J, Larsen JP, Tysnes OB, Toft M (2017) The GBA variant E326K is associated with Parkinson\u2019s disease and explains a genome-wide association signal. Neurosci Lett 658:48\u201352. https:\/\/doi.org\/10.1016\/j.neulet.2017.08.040","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"636_CR9","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1016\/j.expneurol.2004.08.021","volume":"191","author":"R Betarbet","year":"2005","unstructured":"Betarbet R, Sherer TB, Greenamyre JT (2005) Ubiquitin proteasome system and Parkinson\u2019s diseases. Exp Neurol 191(Suppl 1):S17\u2013S27. https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.021","journal-title":"Exp Neurol"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/mds.103","volume":"33","author":"C Blauwendraat","year":"2018","unstructured":"Blauwendraat C, Bras JM, Nalls MA, Lewis PA, Hernandez DG, Singleton AB (2018) International parkinson\u2019s disease genomics consortium. Coding variation in GBA explains the majority of the SYT11-GBA Parkinson\u2019s disease GWAS locus. Mov Disord 33:1821\u20131823. https:\/\/doi.org\/10.1002\/mds.103","journal-title":"Mov Disord"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat Rev Neurosci 8:57\u201369. https:\/\/doi.org\/10.1038\/nrn2038","journal-title":"Nat Rev Neurosci"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.arr.2016.09.004","volume":"35","author":"S Bose","year":"2017","unstructured":"Bose S, Cho J (2017) Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders. Ageing Res Rev 35:155\u2013175. https:\/\/doi.org\/10.1016\/j.arr.2016.09.004","journal-title":"Ageing Res Rev"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1172\/JCI85456","volume":"126","author":"S Brahmachari","year":"2016","unstructured":"Brahmachari S, Ge P, Lee SH, Kim D, Karuppagounder SS, Kumar M, Mao X, Shin JH, Lee Y, Pletnikova O, Troncoso JC, Dawson VL, Dawson TM, Ko HS (2016) Activation of tyrosine kinase c-Abl contributes to \u03b1-synuclein-induced neurodegeneration. J Clin Invest 126:2970\u20132988. https:\/\/doi.org\/10.1172\/JCI85456","journal-title":"J Clin Invest"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.biochem.75.103004.142539","volume":"75","author":"U Brandt","year":"2006","unstructured":"Brandt U (2006) Energy converting NADH: Quinone oxidoreductase (complex I). Annu Rev Biochem 75:69\u201392. https:\/\/doi.org\/10.1146\/annurev.biochem.75.103004.142539","journal-title":"Annu Rev Biochem"},{"key":"636_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal I, Laguna A, Romero-Gim\u00e9nez J, Cuadros T, Bov\u00e9 J, Martinez-Vicente M, Parent A, Gonzalez-Sepulveda M, Pe\u00f1uelas N, Torra A, Rodr\u00edguez-Galv\u00e1n B, Ballabio A, Hasegawa T, Bortolozzi A, Gelpi E, Vila M (2019) Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat Commun 10:973. https:\/\/doi.org\/10.1038\/s41467-019-08858-y","journal-title":"Nat Commun"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1742-2094-7-74","volume":"7","author":"AG Ceulemans","year":"2010","unstructured":"Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Michotte Y (2010) The dual role of the neuroinflammatory response after ischemic stroke: Modulatory effects of hypothermia. J Neuroinflammation 7:74. https:\/\/doi.org\/10.1186\/1742-2094-7-74","journal-title":"J Neuroinflammation"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"12039","DOI":"10.1523\/JNEUROSCI.3568-08.2008","volume":"28","author":"C Cheret","year":"2008","unstructured":"Cheret C, Gervais A, Lelli A, Colin C, Amar L, Ravassard P, Mallet J, Cumano A, Krause KH, Mallat M (2008) Neurotoxic activation of microglia is promoted by a nox1- dependent NADPH oxidase. J Neurosci 28:12039\u201312051. https:\/\/doi.org\/10.1523\/JNEUROSCI.3568-08.2008","journal-title":"J Neurosci"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/s0896-6273(03)00568-3","volume":"39","author":"W Dauer","year":"2003","unstructured":"Dauer W, Przedborski S (2003) Parkinson\u2019s disease: mechanisms and models. Neuron 39:889\u2013909. https:\/\/doi.org\/10.1016\/s0896-6273(03)00568-3","journal-title":"Neuron"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/s0300-9084(01)01250-0","volume":"83","author":"KJA Davies","year":"2001","unstructured":"Davies KJA (2001) Degradation of oxidized proteins by the 20 s proteasome. Biochimie 83:301\u2013310. https:\/\/doi.org\/10.1016\/s0300-9084(01)01250-0","journal-title":"Biochimie"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1093\/brain\/awu131","volume":"137","author":"E Dragicevic","year":"2014","unstructured":"Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B (2014) Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Brain 137:2287\u20132302. https:\/\/doi.org\/10.1093\/brain\/awu131","journal-title":"Brain"},{"key":"636_CR22","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1523\/JNEUROSCI.5311-12.2013","volume":"33","author":"DI Dryanovski","year":"2013","unstructured":"Dryanovski DI, Guzman JN, Xie Z, Galteri DJ, Volpicelli- Daley LA, Lee VM, Miller RJ, Schumacker PT, Surmeier DJ (2013) Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J Neurosci 33:10154\u201310164. https:\/\/doi.org\/10.1523\/JNEUROSCI.5311-12.2013","journal-title":"J Neurosci"},{"key":"636_CR23","doi-asserted-by":"publisher","first-page":"E2253","DOI":"10.1073\/pnas.1616892114","volume":"114","author":"AR Dunn","year":"2017","unstructured":"Dunn AR, Stout KA, Ozawa M, Lohr KM, Hoffman CA, Bernstein AI, Li Y, Wang M, Sgobio C, Sastry N, Cai H, Caudle WH, Miller GW (2017) Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease. Proc Natl Acad Sci USA 114:E2253\u2013E2262. https:\/\/doi.org\/10.1073\/pnas.1616892114","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-011-0828-9","volume":"122","author":"M Elstner","year":"2011","unstructured":"Elstner M, Morris CM, Heim K, Bender A, Mehta D, Jaros E, Klopstock T, Meitinger T, Turnbull DM, Prokisch H (2011) Expression analysis of dopaminergic neurons in Parkinson\u2019s disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol 122:75\u201386. https:\/\/doi.org\/10.1007\/s00401-011-0828-9","journal-title":"Acta Neuropathol"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pneurobio.2005.02.001","volume":"75","author":"H Fedorow","year":"2005","unstructured":"Fedorow H, Tribl F, Halliday G, Gerlach M, Riederer P, Double KL (2005) Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson\u2019s disease. Prog Neurobiol 75:109\u2013124. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.02.001","journal-title":"Prog Neurobiol"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","volume":"84","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z, Amshalom I, Kilarski LL, Bar-Shira A, Gana-Weisz M, Mirelman A, Marder K, Bressman S, Giladi N, Orr-Urtreger A (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology 84:880\u2013887. https:\/\/doi.org\/10.1212\/WNL.0000000000001315","journal-title":"Neurology"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10048-009-0198-9","volume":"11","author":"Z Gan-Or","year":"2010","unstructured":"Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Kedmi M, Giladi N, Orr-Urtreger A (2010) LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. Neurogenetics 11:121\u2013125. https:\/\/doi.org\/10.1007\/s10048-009-0198-9","journal-title":"Neurogenetics"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.molcel.2015.07.012","volume":"59","author":"X Gao","year":"2015","unstructured":"Gao X, Carroni M, Nussbaum-Krammer C, Mogk A, Nillegoda NB, Szlachcic A, Guilbride DL, Saibil HR, Mayer MP, Bukau B (2015) Human Hsp70 disaggregase reverses Parkinson\u2019s-Linked \u03b1-synuclein amyloid fibrils. Mol Cell 59:781\u2013793. https:\/\/doi.org\/10.1016\/j.molcel.2015.07.012","journal-title":"Mol Cell"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators*","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators* (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953. https:\/\/doi.org\/10.1016\/S1474-4422(18)30295-3","journal-title":"Lancet Neurol"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2174\/157015909787602814","volume":"7","author":"JL George","year":"2009","unstructured":"George JL, Mok S, Moses D, Wilkins S, Bush AI, Cherny RA, Finkelstein DI (2009) Targeting the progression of Parkinson\u2019s disease. Curr Neuropharmacol 7:9\u201336. https:\/\/doi.org\/10.2174\/157015909787602814","journal-title":"Curr Neuropharmacol"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, Eggert K, Oertel W, Banati RB, Brooks DJ (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21:404\u2013412. https:\/\/doi.org\/10.1016\/j.nbd.2005.08.002","journal-title":"Neurobiol Dis"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.tibs.2007.06.008","volume":"32","author":"P Goloubinoff","year":"2007","unstructured":"Goloubinoff P, Rios PDL (2007) The mechanism of Hsp70 chaperones: (entropic) pulling the models together. Trends Biochem Sci 32:372\u2013380. https:\/\/doi.org\/10.1016\/j.tibs.2007.06.008","journal-title":"Trends Biochem Sci"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00018-009-0166-4","volume":"67","author":"Q Han","year":"2010","unstructured":"Han Q, Cai T, Tagle DA, Li J (2010) Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci 67:353\u2013368. https:\/\/doi.org\/10.1007\/s00018-009-0166-4","journal-title":"Cell Mol Life Sci"},{"key":"636_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1280","volume":"5","author":"O Hantschel","year":"2004","unstructured":"Hantschel O, Superti-Furga G (2004) Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol 5:33\u201344. https:\/\/doi.org\/10.1038\/nrm1280","journal-title":"Nat Rev Mol Cell Biol"},{"key":"636_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.10277","volume":"52","author":"MA Hern\u00e1n","year":"2002","unstructured":"Hern\u00e1n MA, Takkouche B, Caama\u00f1o-Isorna F, Gestal-Otero JJ (2002) A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson\u2019s disease. Ann Neurol 52:276\u2013284. https:\/\/doi.org\/10.1002\/ana.10277","journal-title":"Ann Neurol"},{"key":"636_CR36","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1006\/nbdi.2000.0289","volume":"7","author":"AJ Herrera","year":"2000","unstructured":"Herrera AJ, Castano A, Venero JL, Cano J, Machado A (2000) The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis 7:429\u2013447. https:\/\/doi.org\/10.1006\/nbdi.2000.0289","journal-title":"Neurobiol Dis"},{"key":"636_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","volume":"334","author":"E Hirsch","year":"1988","unstructured":"Hirsch E, Graybiel AM, Agid YA (1988) Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease. Nature 334:345\u2013348. https:\/\/doi.org\/10.1038\/334345a0","journal-title":"Nature"},{"key":"636_CR38","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1523\/JNEUROSCI.19-09-03440.1999","volume":"19","author":"S Hunot","year":"1999","unstructured":"Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debr\u00b4e P, Agid Y, Dugas B, Hirsch EC (1999) FcepsilonRII\/CD23 is expressed in Parkinson\u2019s disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19:3440\u20133447. https:\/\/doi.org\/10.1523\/JNEUROSCI.19-09-03440.1999","journal-title":"J Neurosci"},{"key":"636_CR39","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","volume":"136","author":"MJ Hurley","year":"2013","unstructured":"Hurley MJ, Brandon B, Gentleman SM, Dexter DT (2013) Parkinson\u2019s disease is associated with altered expression of CaV1 channels and calcium-binding proteins. Brain 136:2077\u20132097. https:\/\/doi.org\/10.1093\/brain\/awt134","journal-title":"Brain"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1471-4159.2003.01841.x","volume":"86","author":"DH Hyun","year":"2003","unstructured":"Hyun DH, Lee M, Halliwell B, Jenner P (2003) Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 86:363\u2013373. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01841.x","journal-title":"J Neurochem"},{"key":"636_CR41","doi-asserted-by":"publisher","first-page":"e65129","DOI":"10.1371\/journal.pone.0065129","volume":"8","author":"SZ Imam","year":"2013","unstructured":"Imam SZ, Trickler W, Kimura S, Binienda ZK, Paule MG, Slikker W Jr, Li S, Clark RA, Ali SF (2013) Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor ina murine Parkinson\u2019s disease model. PLoS One 8:e65129. https:\/\/doi.org\/10.1371\/journal.pone.0065129","journal-title":"PLoS One"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic J (2008) Parkinson\u2019s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79:368\u2013376. https:\/\/doi.org\/10.1136\/jnnp.2007.131045","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"636_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2018.03.017","volume":"674","author":"H Jin","year":"2018","unstructured":"Jin H, Chen J, Li K, Zhang JR, Gu CC, Mao CJ, Yang YP, Wang F, Liu CF (2018) A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson\u2019s disease in Han Chinese patients. Neurosci 674:66\u201369. https:\/\/doi.org\/10.1016\/j.neulet.2018.03.017","journal-title":"Neurosci"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","volume":"15","author":"HH Kampinga","year":"2016","unstructured":"Kampinga HH, Bergink S (2016) Heat shock proteins as potential targets for protective strategies in neurodegeneration. Lancet Neurol 15:748\u2013759. https:\/\/doi.org\/10.1016\/S1474-4422(16)00099-5","journal-title":"Lancet Neurol"},{"key":"636_CR45","doi-asserted-by":"publisher","unstructured":"Kampinga HH, Hageman M, Vos MJ, Kubota H, Tanguay RM, Bruford ME, Cheetham EA, Chen B, Hightower LE (2009) Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 14:105\u2013111. https:\/\/doi.org\/10.1007\/s12192-008-0068-7","DOI":"10.1007\/s12192-008-0068-7"},{"key":"636_CR46","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1196\/annals.1299.125","volume":"1010","author":"AG Kanthasamy","year":"2003","unstructured":"Kanthasamy AG, Kitazawa M, Kaul S, Yang Y, Lahiri DK, Anantharam V, Kanthasamy A (2003) Proteolytic activation of proapoptotic kinase pkc \u03b4 is regulated by overexpression of Bcl_2. Ann N Y Acad Sci 1010:683\u2013686. https:\/\/doi.org\/10.1196\/annals.1299.125","journal-title":"Ann N Y Acad Sci"},{"key":"636_CR47","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1523\/JNEUROSCI.0984-06.2006","volume":"26","author":"PM Keeney","year":"2006","unstructured":"Keeney PM, Xie J, Capaldi RA, Bennett JP Jr (2006) Parkinson\u2019s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 26:5256\u20135264. https:\/\/doi.org\/10.1523\/JNEUROSCI.0984-06.2006","journal-title":"J Neurosci"},{"key":"636_CR48","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1523\/JNEUROSCI.0143-10.2010","volume":"30","author":"ZM Khaliq","year":"2010","unstructured":"Khaliq ZM, Bean BP (2010) Pacemaking in dopaminergic ventral tegmental area neurons: Depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci 30:7401\u20137413. https:\/\/doi.org\/10.1523\/JNEUROSCI.0143-10.2010","journal-title":"J Neurosci"},{"key":"636_CR49","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/scdb.2001.0282","volume":"12","author":"IG Kirkinezos","year":"2001","unstructured":"Kirkinezos IG, Moraes CT (2001) Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol 12:449\u2013457. https:\/\/doi.org\/10.1006\/scdb.2001.0282","journal-title":"Semin Cell Dev Biol"},{"key":"636_CR50","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-006-0086-4","volume":"112","author":"E Knyihar-Csillik","year":"2006","unstructured":"Knyihar-Csillik E, Chadaide Z, Mihaly A, Krisztin-Peva B, Fenyo R, Vecsei L (2006) Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra. Acta Neuropathol. 112:127\u2013137. https:\/\/doi.org\/10.1007\/s00401-006-0086-4","journal-title":"Acta Neuropathol."},{"key":"636_CR51","doi-asserted-by":"publisher","unstructured":"Knyihar-Csillik E, Csillik B, Pakaski M, Krisztin-Peva B, Dobo E, Okuno E, Vecsei L (2004) Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treatment. Neuroscience 126:899\u2013914. https:\/\/doi.org\/10.1016\/j.neuroscience.2004.04.043","DOI":"10.1016\/j.neuroscience.2004.04.043"},{"key":"636_CR52","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1016\/j.peptides.2006.03.032","volume":"27","author":"EO Koylu","year":"2006","unstructured":"Koylu EO, Balkan B, Kuhar MJ, Pogun S (2006) Cocaine and Amphetamine Regulated Transcript (CART) and the stress response. Peptides 27:1956\u20131969. https:\/\/doi.org\/10.1016\/j.peptides.2006.03.032","journal-title":"Peptides"},{"key":"636_CR53","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/nm1314","volume":"11","author":"MJ LaVoie","year":"2005","unstructured":"LaVoie MJ, Ostaszewski BL, Weihofen A, Schlossmacher MG, Selkoe DJ (2005) Dopamine covalently modifies and functionally inactivates parkin. Nat Med 11:1214\u20131221. https:\/\/doi.org\/10.1038\/nm1314","journal-title":"Nat Med"},{"key":"636_CR54","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tibs.2015.04.005","volume":"40","author":"RW Ledeen","year":"2015","unstructured":"Ledeen RW, Wu G (2015) The multi-tasked life of GM1 ganglioside, a true factotum of nature. Trends Biochem Sci 40:407\u2013418. https:\/\/doi.org\/10.1016\/j.tibs.2015.04.005","journal-title":"Trends Biochem Sci"},{"key":"636_CR55","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nn.3500","volume":"16","author":"Y Lee","year":"2013","unstructured":"Lee Y, Karuppagounder SS, Shin JH, Lee YII, Ko HS, Swing D, Jiang H, Kang SU, Lee BD, Kang HC, Kim D, Tessarollo L, Dawson VL, Dawson TM (2013) Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss. Nat Neurosci 16:1392\u20131400. https:\/\/doi.org\/10.1038\/nn.3500","journal-title":"Nat Neurosci"},{"key":"636_CR56","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/j.cellsig.2007.06.015","volume":"19","author":"W Lu","year":"2007","unstructured":"Lu W, Lee HK, Xiang C, Finniss S, Brodie C (2007) The phosphorylation of tyrosine 332 is necessary for the caspase 3- dependent cleavage of PKC\u03b4 and the regulation of cell apoptosis. Cell Signal 19:2165\u20132173. https:\/\/doi.org\/10.1016\/j.cellsig.2007.06.015","journal-title":"Cell Signal"},{"key":"636_CR57","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/hmg\/ddt674","volume":"23","author":"AL Mahul-Mellier","year":"2014","unstructured":"Mahul-Mellier AL, Fauvet B, Gysbers A, Dikiy I, Oueslati A, Georgeon S, Lamontanara AJ, Bisquertt A, Eliezer D, Masliah E, Halliday G, Hantschel O, Lashuel HA (2014) C-Abl phosphorylates alpha-synuclein and regulates its degradation: implication for alpha-synuclein clearance and contribution to the pathogenesis of Parkinsons disease. Hum Mol Genet 23:2858\u20132879. https:\/\/doi.org\/10.1093\/hmg\/ddt674","journal-title":"Hum Mol Genet"},{"key":"636_CR58","doi-asserted-by":"publisher","first-page":"762139","DOI":"10.1155\/2011\/762139","volume":"2011","author":"P Mao","year":"2011","unstructured":"Mao P (2011) Potential antidepressant role of neurotransmitter CART: implications for mental disorders. Depress Res Treat 2011:762139. https:\/\/doi.org\/10.1155\/2011\/762139","journal-title":"Depress Res Treat"},{"key":"636_CR59","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1471-4159.2002.01190.x","volume":"83","author":"PJ McLean","year":"2002","unstructured":"McLean PJ, Kawamata H, Shariff S, Hewett J, Sharma N, Ueda K, Breakefield XO, Hyman BT (2002) TorsinA and heat shock proteins act as molecular chaperones: Suppression of \u03b1-synuclein aggregation. J Neurochem 83:846\u2013854. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.01190.x","journal-title":"J Neurochem"},{"key":"636_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0304-3940(00)01701-8","volume":"297","author":"KS McNaught","year":"2001","unstructured":"McNaught KS, Jenner P (2001) Proteasomal function is impaired in substantia nigra in Parkinson\u2019s Disease. Neurosci Lett 297:191\u2013194. https:\/\/doi.org\/10.1016\/s0304-3940(00)01701-8","journal-title":"Neurosci Lett"},{"key":"636_CR61","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1006\/exnr.2002.8050","volume":"179","author":"KStP McNaught","year":"2003","unstructured":"McNaught KStP, Belizaire R, Isacson O, Jenner P, Olanow CW (2003) Altered proteasomal function in sporadic Parkinson\u2019s disease. Exp Neurol 179:38\u201346. https:\/\/doi.org\/10.1006\/exnr.2002.8050","journal-title":"Exp Neurol"},{"key":"636_CR62","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T (1996) Interleukin (IL)-1beta, IL-2, IL-4, IL 6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett 211:13\u201316. https:\/\/doi.org\/10.1016\/0304-3940(96)12706-3","journal-title":"Neurosci Lett"},{"key":"636_CR63","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fphys.2020.00361","volume":"11","author":"S Momtaz","year":"2020","unstructured":"Momtaz S, Memariani Z, El-Senduny FF, Sanadgol N, Golab F, Katebi M, Abdolghaffari AM, Farzaei MH, Abdollahi M (2020) Targeting ubiquitin-proteasome pathway by natural products: Novel therapeutic strategy for treatment of neurodegenerative diseases. Front Physiol 11:361. https:\/\/doi.org\/10.3389\/fphys.2020.00361","journal-title":"Front Physiol"},{"key":"636_CR64","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.1523\/JNEUROSCI","volume":"25","author":"EMY Moresco","year":"2005","unstructured":"Moresco EMY, Donaldson S, Williamson A, Koleske AJ (2005) Integrin mediated dendrite branch maintenance requires Abelson (Abl) family kinases. J Neurosci 25:6105\u20136118. https:\/\/doi.org\/10.1523\/JNEUROSCI","journal-title":"J Neurosci"},{"key":"636_CR65","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1101\/gad.12.24.3788","volume":"12","author":"RI Morimoto","year":"1998","unstructured":"Morimoto RI (1998) Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev 12:3788\u20133796. https:\/\/doi.org\/10.1101\/gad.12.24.3788","journal-title":"Genes Dev"},{"key":"636_CR66","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62:218\u2013229. https:\/\/doi.org\/10.1016\/j.neuron.2009.01.033","journal-title":"Neuron"},{"key":"636_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1\u201313. https:\/\/doi.org\/10.1042\/BJ20081386","journal-title":"Biochem J"},{"key":"636_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2015.00057","volume":"2","author":"NB Nillegoda","year":"2015","unstructured":"Nillegoda NB, Bukau B (2015) Metazoan Hsp70-based protein disaggregases: emergence and mechanisms. Front Mol Biosci 2:1\u201312. https:\/\/doi.org\/10.3389\/fmolb.2015.00057","journal-title":"Front Mol Biosci"},{"key":"636_CR69","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1002\/mds.21013","volume":"21","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, McNaught KS (2006) Ubiquitin-proteasome system and Parkinson\u2019s disease. Mov Disord 21:1806\u20131823. https:\/\/doi.org\/10.1002\/mds.21013","journal-title":"Mov Disord"},{"key":"636_CR70","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1242\/jcs.024653","volume":"121","author":"X Qi","year":"2008","unstructured":"Qi X, Mochly-Rosen D (2008) The PKC\u03b4-Abl complex communicates ER stress to the mitochondria-an essential step in subsequent apoptosis. J Cell Sci 121:804\u2013813. https:\/\/doi.org\/10.1242\/jcs.024653","journal-title":"J Cell Sci"},{"key":"636_CR71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","volume":"117","author":"L Qian","year":"2010","unstructured":"Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy. J Neural Transm 117:971\u2013979. https:\/\/doi.org\/10.1007\/s00702-010-0428-1","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"636_CR72","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.schres.2013.07.008","volume":"149","author":"TL Ramsey","year":"2013","unstructured":"Ramsey TL, Liu Q, Massey BW, Brennan MD (2013) Genotypic variation in the SV2C gene impacts response to atypical antipsychotics the CATIE study. Schizophr Res 149(1\u20133):21\u201325. https:\/\/doi.org\/10.1016\/j.schres.2013.07.008","journal-title":"Schizophr Res"},{"key":"636_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejmg.2018.05.005","volume":"62","author":"JA Ruskey","year":"2019","unstructured":"Ruskey JA, Greenbaum L, Ronciere L, Alam A, Spiegelman D, Liong C, Levy OA, Waters C, Fahn S, Marder KS, Chung W, Yahalom G, Israeli-Korn S, Livneh V, Fay-Karmon T, Alcalay RN, Hassin-Baer S, Gan-Or Z (2019) Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson\u2019s disease. Eur J Med Genet 62:65\u201369. https:\/\/doi.org\/10.1016\/j.ejmg.2018.05.005","journal-title":"Eur J Med Genet"},{"key":"636_CR74","first-page":"129","volume":"103","author":"P Santens","year":"2003","unstructured":"Santens P, Boon P, Van Roost D, Caemaert J (2003) The pathophysiology of motor symptoms in Parkinson\u2019s disease. Acta Neurol Belg 103:129\u2013134","journal-title":"Acta Neurol Belg"},{"key":"636_CR75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jns.2012.10.024","volume":"324","author":"JS Schneider","year":"2013","unstructured":"Schneider JS, Gollomp SM, Sendek S, Colcher A, Cambi F, Du WA (2013) randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson\u2019s disease patients. J Neurol Sci 324:140\u2013148. https:\/\/doi.org\/10.1016\/j.jns.2012.10.024","journal-title":"J Neurol Sci"},{"key":"636_CR76","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jnr.10777","volume":"74","author":"M Shamoto-Nagai","year":"2003","unstructured":"Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T (2003) An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74:589\u2013597. https:\/\/doi.org\/10.1002\/jnr.10777","journal-title":"J Neurosci Res"},{"key":"636_CR77","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","volume":"144","author":"JH Shin","year":"2011","unstructured":"Shin JH, Ko HS, Kang H, Lee Y, Lee YII, Pletinkova O, Troconso JC, Dawson VL, Dawson TM (2011) PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson\u2019s disease. Cell 144:689\u2013702. https:\/\/doi.org\/10.1016\/j.cell.2011.02.010","journal-title":"Cell"},{"key":"636_CR78","first-page":"357","volume":"2","author":"A Sirvent","year":"2012","unstructured":"Sirvent A, Benistant C, Roche S (2012) Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer. Am J Cancer Res 2:357\u2013371","journal-title":"Am J Cancer Res"},{"key":"636_CR79","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1471-4159.2008.05385.x","volume":"106","author":"D Sulzer","year":"2008","unstructured":"Sulzer D, Mosharov E, Talloczy Z, Zucca FA, Simon JD, Zecca L (2008) Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease. J Neurochem 106:24\u201336. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05385.x","journal-title":"J Neurochem"},{"key":"636_CR80","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","volume":"97","author":"D Sulzer","year":"2000","unstructured":"Sulzer D, Bogulavsky J, Larsen KE, Behr G, Karatekin E, Kleinman MH, Turro N, Krantz D, Edwards RH, Greene LA, Zecca L (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc Natl Acad Sci U S A. 97:11869\u201311874. https:\/\/doi.org\/10.1073\/pnas.97.22.11869","journal-title":"Proc Natl Acad Sci U S A."},{"key":"636_CR81","doi-asserted-by":"publisher","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT (2011) The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease. Neuroscience 198:221\u2013231. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.045","DOI":"10.1016\/j.neuroscience.2011.08.045"},{"key":"636_CR82","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fncel.2014.00050","volume":"8","author":"A Tanabe","year":"2014","unstructured":"Tanabe A, Yamamura Y, Kasahara J, Morigaki R, Kaji R, Goto S (2014) A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson\u2019s disease. Front Cell Neurosci 8:124. https:\/\/doi.org\/10.3389\/fncel.2014.00050","journal-title":"Front Cell Neurosci"},{"key":"636_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2018.05.009","volume":"55","author":"A Thaler","year":"2018","unstructured":"Thaler A, Bregman N, Gurevich T, Shiner T, Dror Y, Zmira O, Gan-Or Z, Bar-Shira A, Gana-Weisz M, Orr-Urtreger A, Giladi N, Mirelman A (2018) Parkinson\u2019s disease phenotype is influenced by the severity of the mutations in the GBA gene. Parkinsonism Relat Disord 55:45\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2018.05.009","journal-title":"Parkinsonism Relat Disord"},{"key":"636_CR84","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris GK, Razzaq A, Ghetti B, Lilley KS, Spillantini MG (2003) Ubiquitination of alpha-synuclein in Lewy Bodies is a pathological event not associated with impairment of proteasome function. J Biol Chem 278:44405\u201344411. https:\/\/doi.org\/10.1074\/jbc.M308041200","journal-title":"J Biol Chem"},{"key":"636_CR85","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1113\/jphysiol.2003.049478","volume":"552","author":"JF Turrens","year":"2003","unstructured":"Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335\u2013344. https:\/\/doi.org\/10.1113\/jphysiol.2003.049478","journal-title":"J Physiol"},{"key":"636_CR86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/bj1910421","volume":"191","author":"JF Turrens","year":"1990","unstructured":"Turrens JF, Boveris A (1990) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191:421\u2013427. https:\/\/doi.org\/10.1042\/bj1910421","journal-title":"Biochem J"},{"key":"636_CR87","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1046\/j.1471-4159.2001.00548.x","volume":"79","author":"TV Votyakova","year":"2001","unstructured":"Votyakova TV, Reynolds I (2001) \u2206\u03a8m-dependent and -independent production of reactive oxygen species by rat brain mitochondria. J Neurochem 79:266\u2013277. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00548.x","journal-title":"J Neurochem"},{"key":"636_CR88","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/en.2005-0812","volume":"147","author":"T Yanik","year":"2006","unstructured":"Yanik T, Dominguez G, Kuhar MJ, Del Giudice EM, Loh YP (2006) The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: A possible cause for obesity in humans. Endocrinology 147:39\u201343. https:\/\/doi.org\/10.1210\/en.2005-0812","journal-title":"Endocrinology"},{"key":"636_CR89","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1073\/pnas.0404161101","volume":"101","author":"D Yao","year":"2004","unstructured":"Yao D, Gu Z, Nakamura T, Shi ZQ, Ma Y, Gaston B, Palmer LA, Rockenstein EM, Zhang Z, Masliah E, Uehara T, Lipton SA (2004) Nitrosative stress linked to sporadic Parkinson\u2019s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 101:10810\u201310814. https:\/\/doi.org\/10.1073\/pnas.0404161101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"636_CR90","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00702-010-0573-6","volume":"118","author":"D Zadori","year":"2010","unstructured":"Zadori D, Nyiri G, Szonyi A, Szatmari I, Fulop F, Toldi J, Freund TF, Vecsei L, Klivenyi P (2010) Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington\u2019s disease. J Neural Transm 118:865\u2013875. https:\/\/doi.org\/10.1007\/s00702-010-0573-6","journal-title":"J Neural Transm"},{"key":"636_CR91","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1440-1681.2011.05642.x","volume":"39","author":"M Zhang","year":"2011","unstructured":"Zhang M, Han L, Xu Y (2011) Roles of cocaine- and amphetamine-regulated transcript in the central nervous system. Clin Exp Pharmacol Physiol 39:586\u2013592. https:\/\/doi.org\/10.1111\/j.1440-1681.2011.05642.x","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-020-00636-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-020-00636-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T19:46:19Z","timestamp":1634845579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-020-00636-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,22]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1007\/s11011-020-00636-w","relation":{},"ISSN":["0885-7490","1573-7365"],"issn-type":[{"value":"0885-7490","type":"print"},{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,22]]},"assertion":[{"value":"11 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We declare that we have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}